logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Recieve alerts
Market:
NYSE
Market Cap:
$37.52 m
Price
0.00
Change
0.00%
52 weeks high
0.87
52 weeks low
0.19
;

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.